Trials / Withdrawn
WithdrawnNCT04351061
Acetazolamide for the Prevention of Post Operative CSF Leak
Pilot Study of Acetazolamide to Prevent Post Operative Cerebrospinal Fluid (CSF) Leak in Patients Undergoing Endoscopic Skull Base Surgery
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to test the use of Acetazolamide in preventing post-operative cerebrospinal fluid leak in patients having endoscopic skull base surgery (it is a surgery performed through the nose and sinus).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetazolamide | Acetazolamide 500 mg by mouth twice per day for 7 consecutive days. |
Timeline
- Start date
- 2020-05-07
- Primary completion
- 2021-11-24
- Completion
- 2021-11-24
- First posted
- 2020-04-17
- Last updated
- 2021-12-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04351061. Inclusion in this directory is not an endorsement.